In addition, our most recent study demonstrated that serum response factor (SRF)/myocardin pathway acts as a pivotal mediator of aortic VSMC stiffening and plays a central role in the pathological aortic stiffening in hypertension [10]. The gene discussed is MYOCD; the disease is hypertensive disorder.